|
Mar 14
|
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
|
|
Mar 13
|
3 Small-Cap Stocks Skating on Thin Ice
|
|
Mar 4
|
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
|
|
Mar 4
|
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
|
|
Mar 3
|
Does The Market Have A Low Tolerance For Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Fundamentals?
|
|
Mar 2
|
Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stock to Buy Now?
|
|
Feb 27
|
Supernus to Participate in the TD Cowen 45th Annual Health Care Conference
|
|
Feb 24
|
What To Expect From Supernus Pharmaceuticals’s (SUPN) Q4 Earnings
|
|
Feb 19
|
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
|
|
Feb 18
|
Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
|
|
Feb 11
|
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
|
|
Oct 9
|
Supernus Pharmaceuticals Inc (SUPN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Sep 24
|
Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree
|
|
Sep 24
|
Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
|
|
Sep 19
|
Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
|
|
Aug 8
|
Supernus Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
|
|
Aug 7
|
Supernus (SUPN) Reports Q2 Earnings: What Key Metrics Have to Say
|
|
Aug 6
|
Supernus Pharmaceuticals (SUPN) Misses Q2 Earnings Estimates
|
|
Aug 6
|
Supernus: Q2 Earnings Snapshot
|
|
Aug 6
|
Supernus Announces Second Quarter 2024 Financial Results
|